Thiazolidinediones are currently indicated for the treatment of Type 2 Diabetes. This class of drugs has been associated with several adverse reactions associated with volume overload. This report describes a case of a 65 year old African-American female with a history of hypertension and obesity, and taking rosiglitazone (Avandia) for her Type 2 Diabetes whose evaluation for chest pain resulted in the incidental finding of pulmonary hypertension noted on echocardiogram. The subsequent evaluation, follow-up and treatment are discussed along with potential pitfalls and implications for clinical care.
Introduction
Thiazolidinediones, commonly referred to as glitazones, are currently indicated for the treatment of Type 2 Diabetes. This class of drugs is also associated with several adverse reactions, including volume expansion that presumably, can contribute to heart failure and other adverse cardiovascular events. Congestive heart failure, pulmonary edema, and pleural effusions have been reported, and appear to be dose related. [GSK, 2007] This brief report describes a case of rosiglitazone associated volume expansion masquerading as pulmonary hypertension (PH).
was regular with a 4/6 holosystolic murmur at the left sternal border, extremities with 2+ edema to bilateral lower legs.
Evaluation included a normal exercise thallium; CT scan of chest with contrast showing no acute infiltrates, effusions or pulmonary emboli, normal size of pulmonary vessels; pulmonary function testing revealing normal spirometry, hyperinflation and air trapping, and normal diffusion capacity; and echocardiography showing mild/moderate aortic stenosis (peak velocity 3.1 m/s), normal left ventricular size and systolic function, normal right ventricular size and function, enlarged right atrium, mild mitral regurgitation (MR) and moderate tricuspid regurgitation, and pulmonary artery systolic pressure (PASP) estimated at 62 mmHg. The patient was discharged by her cardiologist within 48 h without further intervention, told to resume home medications, and arranged an outpatient follow-up in 1 week with a pulmonologist to further assess the PH. Subsequent outpatient right heart cardiac catheterization was performed two weeks post discharge. (Table 1) Outpatient polysomnography (PSG) one month post admit revealed a respiratory disturbance index (RDI) = 8.5 events/h, REM-related RDI = 68 events/h, saturation nadir of 78%. Continuous positive airway pressure (CPAP) was Repeat right heart cardiac catheterization was performed to confirm echo findings (Table 1) along with a Pro-BNP level of 315, negative serology, glomerular filtration rate (GFR) of 44 mL/min, and normal red cell indices.
(See Table 2 for renal function over time). Rosiglitazone was discontinued and tiotropium bromide started with follow up three months later still on CPAP. Patient feeling much improved with resolution of edema, and symptoms. Blood pressure 140/78, pulse of 86, respiration Implications for clinical care PH has been in the academic spotlight over the last several years due in part to the advent of new drugs for its treatment but more importantly to the call and need for a more rigorous approach to its diagnostic evaluation than has been practiced in the past. Recent guidelines and their update have been published iterating and reinforcing this approach, [Badesch et al. 2007; ACCP, 2004] . Many question remain regarding the most efficacious therapy for patients with pulmonary arterial hypertension (PAH), but what is to be avoided is the use of these expensive medications for pulmonary venous hypertension. 
Review
Argument may be made to have performed left heart catheterization as well, considering the patient's history of aortic stenosis and probable diastolic dysfunction. It is doubtful, however, that this would have made a difference in her outcome taking into account three serial echocardiograms that were consistent in not revealing a critical valve area, as well as ultimate symptom improvement despite a reduction in valve area. It can be assumed that LVEDP would have been at least minimally elevated, and her diuretic was increased with this in mind. Regardless, cardiac catheterization is paramount before treatment is considered.
Sleep apnea could also be contributing, [Atwood et al. 2004] and although the literature is somewhat vague regarding extent, typically a three month trial of CPAP is used to gauge its effect on pulmonary artery pressure determined echocardiographically. This patient's symptoms and PASP became worse despite three months of compliant CPAP use, which, for some clinicians, would be reason enough for the immediate start of PH medications.
Thiazolidinediones as monotherapy for Type 2 diabetes have been documented to result in edema in 5% of patients, which triples in frequency when combined with another oral hypoglycemic agent. [Raskin et al. 2001; Rubin et al. 1999] . Recent press has implicated thiazolidinediones in raising the risk of myocardial infarction. [Nissen and Wolski, 2007] . To date, no report has described the association of thiazolidinediones with PH, but it follows that the related volume overload can accelerate, or directly result in, the development of PH in the setting of obesity and diastolic dysfunction. [Alpert, 2001] As the patient's cardiac output increased to accommodate volume expansion, the degree of diastolic dysfunction commensurately increased, especially with exertion, resulting in worsening symptoms of pulmonary venous hypertension. The patient was refractory to an increase in diuretic dose, which is also documented with volume overload associated with the thiazolidinediones. [Niemeyer and Janney, 2002; Wang et al. 2002] . Discontinuation of rosiglitazone resulted in relatively rapid resolution of her edema and symptoms, with normalization of PASP by echocardiography.
In summary, PH is a complex disease that is but an end result of a panoply of various disorders, and is becoming a more frequently listed and prevalent diagnosis. [MMWR, 2005] Its complicated evaluation makes the opportunity for misdiagnosis and maltreatment more common. Being familiar with the ACCP Guidelines can help avoid common pitfalls. Once PH is determined echocardiographically the importance of confirmatory right (and possibly left) heart cardiac catheterization cannot be overemphasized. Finally, consideration of side effects of common drugs also warrants particular attention, in this case regarding a thiazolidinedione producing a state of volume overload masquerading as PH.
